Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A novel protein that participates in nonself discrimination of malignant cells by homologous complement

Abstract

The human complement (C) system protects an individual against substances of nonself origin, including xenografts and microbial pathogens1. Human cells express C-regulatory proteins, CD46 and CD55, thereby circumventing attack by C3, a major effector of C (ref. 2). Nevertheless, certain malignant cells, particularly those undergoing apoptotic stress, can activate homologous C, overcoming the regulatory actions of CD46 and/or CD55 (ref. 3–5). The molecular mechanisms whereby malignant cells are tagged by homologous C3 remain largely unknown. We identified a novel gene product that converts human cells into targets for homologous complement. Only malignant cells and cell lines exposed to Fas or X-irradiation stimuli produced this protein, designated M161Ag, which was an unglycosylated 43-kDa protein. Analysis of cloned cDNAs indicated that this molecule was a secretory protein containing five amino acids encoded by TGA codons. Its functions were unique in that once secreted from the tumor cells, it bound back to the surface of these cells and activated homologous complement (C3) via the alternative pathway, allowing for C3 deposition on the membrane. This molecule may offer new insight into innate immunity; surveillance of tumor cells by complement is a common feature in the human immune system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Janeway, C.A., Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11–16 (1992).

    Article  CAS  Google Scholar 

  2. Atkinson, J.P. & Farris, T.C. Separation of self from nonself in the complement system. Immunol. Today 8, 212–213 (1987).

    Article  CAS  Google Scholar 

  3. Ramos, O. F., Sarmay, G., Klein, E., Yefenof, E. & Gergely, J. Complement-dependent cellular cytotoxicity: Lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum. Proc. Natl. Acad. Sci. USA 82, 5470–5474 (1985).

    Article  CAS  Google Scholar 

  4. Seya, T., Hara, T., Matsumoto, M. & Akedo, H. Quantitative analysis of membrane cofactor protein (MCP) of complement: High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J. Immunol. 145, 238–245 (1990).

    CAS  PubMed  Google Scholar 

  5. Matsui, H., Tsuji, S., Nishimura, H. & Nagasawa, S. Activation of the alternative pathway of complement by apoptotic Jurkat cells. FEBS lett. 351, 419–422 (1994).

    Article  CAS  Google Scholar 

  6. Matsumoto, M. & Seya, T. Homologous C3 deposition and homotypic cell adhesion in a human myeloid cell line, P39. Eur. J. Immunol. 23, 2270–2278 (1993).

    Article  CAS  Google Scholar 

  7. Matsumoto, M., Yamashita, F., Iida, K., Tomita, M. & Seya, T. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3. J. Exp. Med. 181, 115–125 (1995).

    Article  CAS  Google Scholar 

  8. Low, S.C. & Berry, M.J. Knowing when not to stop: Selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21, 203–208 (1996).

    Article  CAS  Google Scholar 

  9. Hill, K.E., Lloyd, R.S., Yang, J.-G., Read, R. & Burk, R.F. The cDNA for rat seleno-protein P contains 10 TGA codons in the open reading frame. J. Biol. Chem. 266, 10050–10053 (1991).

    CAS  PubMed  Google Scholar 

  10. Dempsey, P.W., Allison, M.E.D., Akkaraju, S., Goodnow, C.C. & Fearon, D.T. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271, 348–350 (1996).

    Article  CAS  Google Scholar 

  11. Fearon, D.T. & Locksley, R.M. The instructive role of innate immunity in the acquired immune response. Science 272, 50–54 (1996).

    Article  CAS  Google Scholar 

  12. Karp, C.L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228–231 (1996).

    Article  CAS  Google Scholar 

  13. Holmskov, U., Malhotra, R., Sim, R.B. & Jensenius, J.C., Collectins: Collagenous C-type lectins of the innate immune defense system. Immunol. Today 15, 67–74 (1994).

    Article  CAS  Google Scholar 

  14. Umemura, K., Yokota, Y., Kozutsumi, Y. & Kawasaki, T. A unique CD45 glyco-form recognized by the serum mannan-binding protein in immature thymocytes. J. Biol. Chem. 271, 4581–4584 (1996).

    Article  Google Scholar 

  15. Gladyshev, V.N., Jeang, K.-T. & Stadtman, T.C., Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA 93, 6146–6151 (1996).

    Article  CAS  Google Scholar 

  16. Itoh, N. et al. Cloning of an interleukin-3 receptor gene: A member of a distinct receptor gene family. Science 247, 324–327 (1990).

    Article  CAS  Google Scholar 

  17. Matsumoto, M., Seya, T. & Nagasawa, S. Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem. J. 281, 493–499 (1992).

    Article  CAS  Google Scholar 

  18. Kikkawa, S., Matsumoto, M. & Seya, T. Development of monoclonal antibodies against homologous C3 activating molecule, M161Ag. Jpn. Biochem. Soc. 68, 703 (1996) (Abstr.).

  19. Iwai, K. et al. Preparation of a verifiable peptide-protein immunogen: Direction-controlled conjugation of a synthetic fragment of the monitor peptide with myoglobin and application for sequence analysis. Anal. Biochem. 171, 277–282 (1988).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsumoto, M., Takeda, J., Inoue, N. et al. A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat Med 3, 1266–1270 (1997). https://doi.org/10.1038/nm1197-1266

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1197-1266

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing